SIRONAX
Sironax is a clinical-stage biotechnology company that develops novel products and treatments for age-related degenerative diseases. The company is focusing on key mechanisms underlying age-related degenerative diseases including regulated cell death, neuroprotective pathways, and neuroinflammation. They aim to shift the treatment paradigm for age-related degenerative disease to improve the lives of millions of patients and their families around the world. Sironax was founded in 2017 and is based in Beijing, China.
SIRONAX
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2017-09-01
Address:
Beijing, Beijing, China
Country:
China
Website Url:
http://www.sironax.com.cn
Total Employee:
101+
Status:
Active
Contact:
86-10-80765868
Email Addresses:
[email protected]
Total Funding:
301 M USD
Technology used in webpage:
IPv6
Current Employees Featured
Founder
Investors List
Temasek Holdings
Temasek Holdings investment in Series B - Sironax
Future Innovation Fund
Future Innovation Fund investment in Series B - Sironax
Eight Roads Ventures
Eight Roads Ventures investment in Series B - Sironax
Superstring Capital
Superstring Capital investment in Series B - Sironax
F-Prime Capital
F-Prime Capital investment in Series B - Sironax
YF Capital
YF Capital investment in Series B - Sironax
Invus
Invus investment in Series B - Sironax
CBC Group
CBC Group investment in Series B - Sironax
K2 Venture Capital
K2 Venture Capital investment in Series B - Sironax
Gaorong Capital
Gaorong Capital investment in Series B - Sironax
Official Site Inspections
http://www.sironax.com.cn
- Host name: 156.225.111.26
- IP address: 156.225.111.26
- Location: Johannesburg South Africa
- Latitude: -26.2309
- Longitude: 28.0583
- Timezone: Africa/Johannesburg
- Postal: 2000
